Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines

Hepatocellular carcinoma is the fifth most common cancer worldwide and shows a complex clinical course, poor response to pharmacological treatment, and a severe prognosis. Thus, the aim of this study was to investigate whether tacrolimus (FK506) has synergistic antitumor effects with doxorubicin on...

Descripción completa

Detalles Bibliográficos
Autores principales: Capone, Francesca, Guerriero, Eliana, Sorice, Angela, Colonna, Giovanni, Storti, Gabriella, Pagliuca, Jessica, Castello, Giuseppe, Costantini, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951002/
https://www.ncbi.nlm.nih.gov/pubmed/24701168
http://dx.doi.org/10.1155/2014/450390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951002/
https://www.ncbi.nlm.nih.gov/pubmed/24701168
http://dx.doi.org/10.1155/2014/450390

Ejemplares similares